29 Programs
-
Current and Future Role of CD19 x CD3 Bispecific T-Cell Engaging Antibodies in the Treatment of Acute Lymphoblastic Leukemia
-
-
B
-
B
-
-
B
-
B
-
-
Optimal Management of Squamous Cell Carcinoma of the Anal Canal
-
-
M
-
M
-
-
M
-
M
-
-
Novel Investigational Antibody-Drug Conjugates for Ovarian Cancer
-
-
K
-
K
-
-
K
-
K
-
-
The New Understanding of Toxicities Associated with Chimeric Antigen Receptor (CAR) T-Cell Therapy
-
-
M
-
M
-
-
M
-
M
-